Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01534689 · ClinicalTrials.gov registry record · NA
Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus
A NA study of Onychomycosis, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT01534689 is a NA study of Onychomycosis that has completed, run by Erchonia Corporation. The registered enrollment target is 105 participants, above the 85-participant average among 11 other Onychomycosis trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01534689, a NA study of Onychomycosis, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether low level laser light is effective in the treatment of toenail fungus.
Conditions Studied
Interventions
- DEVICE Erchonia FX-405™ Laser
Study Locations (1)
Arizona
- Arizona Institute of Footcare Physicians - Mesa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01534689
The ClinicalTrials.gov registry entry for NCT01534689 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 11 other Onychomycosis trials with a reported enrollment target (24% higher). The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 1 intervention - of which Erchonia FX-405™ Laser is the first listed.
NCT01534689 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT01534689 about?
NCT01534689 is a clinical study titled "Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus". The purpose of this study is to determine whether low level laser light is effective in the treatment of toenail fungus.
What is the current status of trial NCT01534689?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2011-04. Estimated completion is 2012-04.
What conditions does trial NCT01534689 study?
This clinical trial studies the following conditions: Onychomycosis.
What interventions are being tested in trial NCT01534689?
The interventions under investigation include: Erchonia FX-405™ Laser (DEVICE).
Who is sponsoring clinical trial NCT01534689?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01534689 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Onychomycosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
COMPLETED · NA
-
Diode Laser Treatment of Onychomycosis
COMPLETED · NA
-
Bioequivalency Study of Terbinafine Tablets Under Fed Conditions
COMPLETED · NA
-
Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions
COMPLETED · NA
-
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
ACTIVE NOT RECRUITING · Phase 3
-
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.